{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:29:38Z","timestamp":1773347378127,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejps.2021.105854","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T04:16:36Z","timestamp":1618546596000},"page":"105854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Influence of ABC transporters on the excretion of ciprofloxacin assessed with PET imaging in mice"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3700-7690","authenticated-orcid":false,"given":"Irene","family":"Hern\u00e1ndez-Lozano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0404-4452","authenticated-orcid":false,"given":"Thomas","family":"Wanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-3546","authenticated-orcid":false,"given":"Michael","family":"Sauberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Filip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5094-9351","authenticated-orcid":false,"given":"Severin","family":"Mairinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-8781","authenticated-orcid":false,"given":"Johann","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Traxl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1541-7215","authenticated-orcid":false,"given":"Rudolf","family":"Karch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-5781","authenticated-orcid":false,"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejps.2021.105854_bib0001","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1124\/dmd.107.014969","article-title":"Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones","volume":"35","author":"Ando","year":"2007","journal-title":"Drug. Metab. Dispos."},{"issue":"5","key":"10.1016\/j.ejps.2021.105854_bib0002","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/cpt.1506","article-title":"PET imaging of [11C]rosuvastatin hepatic concentrations and hepatobiliary transport in humans in the absence and presence of cyclosporine A","volume":"106","author":"Billington","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ejps.2021.105854_bib0003","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1128\/AAC.48.10.3850-3857.2004","article-title":"[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans","volume":"48","author":"Brunner","year":"2004","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/jpet.105.098665","article-title":"Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2)","volume":"317","author":"Chu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.ejps.2021.105854_bib0005","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.ejps.2021.105854_bib0006","first-page":"1019","article-title":"Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability","volume":"52","author":"Davis","year":"1996","journal-title":"Drug Evaluation"},{"key":"10.1016\/j.ejps.2021.105854_bib0007","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1993.tb12844.x","article-title":"Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers","volume":"108","author":"Griffiths","year":"1993","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejps.2021.105854_bib0008","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1124\/dmd.111.038323","article-title":"Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2)","volume":"39","author":"Haslam","year":"2011","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105854_bib0009","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00140.2015","article-title":"Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function","volume":"309","author":"Henjakovic","year":"2015","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"4","key":"10.1016\/j.ejps.2021.105854_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1208\/s12248-019-0323-0","article-title":"Towards improved pharmacokinetic models for the analysis of transporter-mediated hepatic disposition of drug molecules with positron emission tomography","volume":"21","author":"Hern\u00e1ndez Lozano","year":"2019","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17425255.2020.1718107","article-title":"Use of imaging to assess the activity of hepatic transporters","volume":"16","author":"Hern\u00e1ndez Lozano","year":"2020","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.ejps.2021.105854_bib0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/AAC.27.3.375","article-title":"Pharmacokinetics of ciprofloxacin after oral and parenteral administration","volume":"27","author":"H\u00f6ffken","year":"1985","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.ejps.2021.105854_bib0013","series-title":"Report of the task group on reference man. ICRP Publication 23","author":"ICRP","year":"1975"},{"issue":"5","key":"10.1016\/j.ejps.2021.105854_bib0014","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0009-9236(95)90173-6","article-title":"Effect of probenecid on the distribution and elimination of ciprofloxacin in humans","volume":"58","author":"Jaehde","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ejps.2021.105854_bib0015","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.xphs.2017.04.040","article-title":"Investigation of the importance of multidrug resistance-associated protein 4 (Mrp4\/Abcc4) in the active efflux of anionic drugs across the blood-brain barrier","volume":"106","author":"Kanamitsu","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2021.105854_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/clpt.2013.85","article-title":"Imaging in the study of membrane transporters","volume":"94","author":"Kusuhara","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2125.2009.03564.x","article-title":"Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid","volume":"69","author":"Landersdorfer","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejps.2021.105854_bib0018","first-page":"1835","article-title":"Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans","volume":"46","author":"Langer","year":"2005","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejps.2021.105854_bib0019","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0969-8051(02)00444-4","article-title":"Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans","volume":"30","author":"Langer","year":"2003","journal-title":"Nucl. Med. Biol."},{"issue":"4","key":"10.1016\/j.ejps.2021.105854_bib0020","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1046\/j.1523-1755.2000.00007.x","article-title":"ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2","volume":"57","author":"Leier","year":"2000","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.ejps.2021.105854_bib0021","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0090-9556(25)08544-7","article-title":"Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist","volume":"18","author":"Lin","year":"1990","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105854_bib0022","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1086\/515104","article-title":"Fluoroquinilone toxicity profiles: a review focusing on newer agents","volume":"28","author":"Lipsky","year":"1999","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejps.2021.105854_bib0023","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol. Imaging."},{"key":"10.1016\/j.ejps.2021.105854_bib0024","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/sj.bjp.0704560","article-title":"Multiple pathways for fluoroquinolone secretion by human intestinal (Caco-2) cells","volume":"135","author":"Lowes","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2021.105854_bib0025","first-page":"54","article-title":"Safety of fluoroquinolones: an update","volume":"13","author":"Mandell","year":"2002","journal-title":"Can. J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.ejps.2021.105854_bib0026","doi-asserted-by":"crossref","first-page":"e28368","DOI":"10.1371\/journal.pone.0028368","article-title":"Characterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacin","volume":"6","author":"Marquez","year":"2011","journal-title":"PloS one"},{"issue":"6","key":"10.1016\/j.ejps.2021.105854_bib0027","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/AAC.01428-08","article-title":"Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells","volume":"53","author":"Marquez","year":"2009","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"8","key":"10.1016\/j.ejps.2021.105854_bib0028","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ejps.2021.105854_bib0029","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1124\/dmd.110.034512","article-title":"Role of breast cancer resistance protein in the adaptive response to cholestasis","volume":"38","author":"Mennone","year":"2010","journal-title":"Drug. Metab. Dispos."},{"issue":"4","key":"10.1016\/j.ejps.2021.105854_bib0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/dmd.105.008219","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion","volume":"34","author":"Merino","year":"2006","journal-title":"Drug. Metab. Dispos."},{"issue":"11","key":"10.1016\/j.ejps.2021.105854_bib0031","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1124\/dmd.107.016352","article-title":"Evaluation of the role of breast cancer resistance protein (BCRP\/ABCG2) and multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one)","volume":"35","author":"Mizuno","year":"2007","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105854_bib0032","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/B978-012744482-6.50026-0","article-title":"Kinetic Modeling in Positron Emission Tomography","author":"Morris","year":"2004","journal-title":"Emission Tomography: The Fundamentals of PET and SPECT"},{"issue":"5","key":"10.1016\/j.ejps.2021.105854_bib0033","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/17425255.2012.674512","article-title":"Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters","volume":"8","author":"Mulgaonkar","year":"2012","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0034","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/jpet.108.142257","article-title":"Functional characterization of multidrug and toxin extrusion protein 1 as a facilitative transporter for fluoroquinolones","volume":"328","author":"Ohta","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.ejps.2021.105854_bib0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1165\/rcmb.2012-0275MA","article-title":"Imaging of activity of multidrug resistance-associated protein 1 in the lungs","volume":"49","author":"Okamura","year":"2013","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejps.2021.105854_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1753-5174.2010.00032.x","article-title":"Is Ciprofloxacin a substrate of P-glycoprotein?","volume":"4","author":"Park","year":"2011","journal-title":"Arch. Drug. Inf."},{"issue":"12","key":"10.1016\/j.ejps.2021.105854_bib0037","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.116.072066","article-title":"Abundance of drug transporters in the human kidney cortex as quantified by quantitative targeted proteomics","volume":"44","author":"Prasad","year":"2016","journal-title":"Drug. Metab. Dispos."},{"issue":"5","key":"10.1016\/j.ejps.2021.105854_bib0038","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1124\/mol.63.5.1094","article-title":"Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5","volume":"63","author":"Reid","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000238751","article-title":"Transintestinal elimination of ciprofloxacin","volume":"36","author":"Rohwedder","year":"1990","journal-title":"Chemotherapy"},{"issue":"8","key":"10.1016\/j.ejps.2021.105854_bib0040","first-page":"2538","article-title":"Quantitative evaluation of mMate1 function based on minimally invasive measurement of tissue concentration using PET with [11C]metformin in mouse","volume":"32","author":"Shingaki","year":"2015","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ejps.2021.105854_bib0041","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejps.2005.12.003","article-title":"Transporters as a determinant of drug clearance and tissue distribution","volume":"27","author":"Shitara","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5A","key":"10.1016\/j.ejps.2021.105854_bib0042","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9343(89)90025-9","article-title":"Brief report: gastrointestinal secretion of ciprofloxacin","volume":"87","author":"S\u00f6rgel","year":"1989","journal-title":"Am. J. Med"},{"key":"10.1016\/j.ejps.2021.105854_bib0043","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.apradiso.2015.02.024","article-title":"Automated radiosynthesis of [18F]ciprofloxacin","volume":"99","author":"Stanek","year":"2015","journal-title":"Appl. Radiat. Isot."},{"issue":"14","key":"10.1016\/j.ejps.2021.105854_bib0044","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1158\/0008-5472.CAN-06-4720","article-title":"Substrate overlap between Mrp4 and Abcg2\/Bcrp affects purine analogue drug cytotoxicity and tissue distribution","volume":"67","author":"Takenaka","year":"2007","journal-title":"Cancer. Res."},{"key":"10.1016\/j.ejps.2021.105854_bib0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2018.04.006","article-title":"Imaging techniques to study drug transporter function in vivo","volume":"189","author":"Tournier","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0046","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jps.24645","article-title":"Quantitative targeted absolute proteomics for 28 transporters in brush-border and basolateral membrane fractions of rat kidney","volume":"105","author":"Uchida","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105854_bib0047","volume":"425","author":"Ullrich","year":"1993","journal-title":"Pfl\u00fcgers Arch."},{"issue":"1","key":"10.1016\/j.ejps.2021.105854_bib0048","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.107.042853","article-title":"Organic anion transporter 3 (oat3\/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin","volume":"74","author":"Vanwert","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps060213","article-title":"Permeability classification of representative fluoroquinolones by a cell culture method","volume":"6","author":"Volpe","year":"2004","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.ejps.2021.105854_bib0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.xphs.2015.11.014","article-title":"Influence of 24-nor-ursodeoxycholic acid on hepatic disposition of [18F]ciprofloxacin, a positron emission tomography study in mice","volume":"105","author":"Wanek","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2021.105854_bib0051","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11307-018-1230-y","article-title":"Influence of multidrug resistance-associated proteins on the excretion of the ABCC1 imaging probe 6-Bromo-7-[11C]Methylpurine in mice","volume":"21","author":"Zoufal","year":"2019","journal-title":"Mol. Imaging. Biol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:57:00Z","timestamp":1760529420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":51,"alternative-id":["S0928098721001561"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105854","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of ABC transporters on the excretion of ciprofloxacin assessed with PET imaging in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105854"}}